Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.

Zeynep Eroglu,Shifra Krinshpun,Ekaterina Kalashnikova,Sumedha Sudhaman,Turkan Ozturk Topcu, Matt Nichols,Justin Martin, Katherine M Bui,Charuta C Palsuledesai,Meenakshi Malhotra,Perry Olshan,Joseph Markowitz,Nikhil I Khushalani,Ahmad A Tarhini,Jane L Messina,Alexey Aleshin

Cancer（2023）

引用 4|浏览12

暂无评分

摘要

Personalized and tumor-informed longitudinal ctDNA monitoring is a valuable prognostic and predictive tool that may be used throughout the clinical course of patients with advanced melanoma.

查看译文

关键词

advanced melanoma,circulating tumor DNA (ctDNA),immune checkpoint inhibitors (ICI),molecular residual disease (MRD),treatment monitoring

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要